L065-0134 Screening compound: methyl 3-[(3-{5-[(4-methoxyphenyl)carbamoyl]-1,3,4-thiadiazol-2-yl}piperidine-1-carbonyl)amino]benzoate

L065-0134 Screening compound: methyl 3-[(3-{5-[(4-methoxyphenyl)carbamoyl]-1,3,4-thiadiazol-2-yl}piperidine-1-carbonyl)amino]benzoate
L065-0134 Screening compound: methyl 3-[(3-{5-[(4-methoxyphenyl)carbamoyl]-1,3,4-thiadiazol-2-yl}piperidine-1-carbonyl)amino]benzoate alternative view

Chemical Structure Depiction of ChemDiv screening compound L065-0134
methyl 3-[(3-{5-[(4-methoxyphenyl)carbamoyl]-1,3,4-thiadiazol-2-yl}piperidine-1-carbonyl)amino]benzoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L065-0134

Molecular Formula

C24H25N5O5S (C24 H25 N5 O5 S)

Compound Name

methyl 3-[(3-{5-[(4-methoxyphenyl)carbamoyl]-1,3,4-thiadiazol-2-yl}piperidine-1-carbonyl)amino]benzoate

IUPAC name

methyl 3-[(3-{5-[(4-methoxyphenyl)carbamoyl]-134-thiadiazol-2-yl}piperidine-1-carbonyl)amino]benzoate

SMILES

COC(c1cccc(NC(N(CCC2)CC2c2nnc(C(Nc(cc3)ccc3OC)=O)s2)=O)c1)=O

InChI

InChI=1S/C24H25N5O5S/c1-33-19-10-8-17(9-11-19)25-20(30)22-28-27-21(35-22)16-6-4-12-29(14-16)24(32)26-18-7-3-5-15(13-18)23(31)34-2/h3,5,7-11,13,16H,4,6,12,14H2,1-2H3,(H,25,30)(H,26,32)/t16-/m0/s1

InChI Key

UOBHBYHNZSVZRR-INIZCTEOSA-N

MDL Number (MFCD)

MFCD27228566

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

495.56

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

3.802

Distribution Coefficient, logD

3.802

Water Solubility, LogSw

-4.03

Polar Surface Area

100.682

Acid Dissociation Constant (pKa)

11.08

Base Dissociation Constant (pKb)

-0.34

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

29.20

L065-0134 in Drug Discovery

Included in Screening Libraries

Protein Kinases Inhibitors Library (36801 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with L065-0134 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L065-0134?
Check Price and Availability of L065-0134, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L065-0134 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L065-0134
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L065-0134
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L065-0134 available by request